R.E.B.E.L.EM - October 11, 2018 - By Salim Rezzaie
"Author Conclusion: “Compared with other SOC approaches use of CCTA is associated with similar major adverse cardiac events but higher rates of revascularization in patients with acute chest pain.”
Clinical Take Home Point: In patients that are deemed “low risk” for atherosclerotic disease, with no previous diagnosis of coronary artery disease the use of CCTA compared to standard of care physiologic testing decreases length of stay, increases downstream testing (invasive coronary angiography and revascularization), without any patient oriented benefit all-cause mortality, MI, MACE) and should not be used in this patient population."